Track 6: Pharmaceutical and Biotech CEO/CFO/Chief Strategy Officer Summit
January 30th - February 1st, 2005
   
Marriott Wardman Park Hotel - Washington, D.C.

Track 6: Pharmaceutical and Biotech CEO/CFO/Chief Strategy Officer Summit

Sponsors:

In association with: Pharmaceutical Law & Litigation, PharmaVoice, American Pharmaceutical Review
Monday
11:15AM-12:00PM Advancing R&D Productivity through Business Models and Clinical Trials
  • Technology implementation to speed clinical trials and FDA approval
  • Review of electronic data capture and data mining strategies for new drug development

Joe Feczko, MD, Vice President, Pfizer Inc.; President of Worldwide Development, Pfizer Global Pharmaceuticals
1:30PM-2:15PM Anticipating the FDA Regulatory Environment for Product Review and Approval
  • FDA’s efforts to improve regulatory reporting

Janet Woodcock, M.D., Acting Deputy Commissioner for Operations, Food and Drug Administration
2:30PM-3:15PM Public Perceptions -- Influencing the External Environment

Moderator:
Nancy Turett, President and Global Director, Health, Edelman

David Brennan, President and CEO, AstraZeneca US
Tuesday
10:45AM-11:30AM Critical Condition: The Ills of the U.S. Health Care System and How We Can Heal Them

Sidney Taurel, Chairman, President and CEO, Eli Lilly and Company
11:45AM-12:30PM Breaking Down the Silos – How Biopharmaceutical Companies Can Become Part of the Emerging Healthcare Delivery Continuum

William Haseltine, Ph.D., Chairman and CEO, Human Genome Sciences
Back to Top >>
 

Gold
Sponsors:

 
Foundation Sponsor
 
Educational Underwriters











 
 
Career
Opportunities